primary antibodies against cited2 (Proteintech)
Structured Review

Primary Antibodies Against Cited2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/primary antibodies against cited2/product/Proteintech
Average 93 stars, based on 3 article reviews
Images
1) Product Images from "Cited2 inhibited hypoxia-induced proliferation and migration of PASMCs via the TGF-β1/Cited2/PPARγ pathway"
Article Title: Cited2 inhibited hypoxia-induced proliferation and migration of PASMCs via the TGF-β1/Cited2/PPARγ pathway
Journal: Iranian Journal of Basic Medical Sciences
doi: 10.22038/IJBMS.2023.74455.16178
Figure Legend Snippet: Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) expression was down-regulated in hypoxia-induced pulmonary hypertension (HPH) rat models
Techniques Used: Expressing
Figure Legend Snippet: Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) expression was down-regulated in pulmonary artery smooth muscle cells (PASMCs) in hypoxia
Techniques Used: Expressing
Figure Legend Snippet: Effects of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) overexpression on pulmonary artery smooth muscle cells (PASMCs)
Techniques Used: Over Expression
Figure Legend Snippet: Effects of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) knockdown on pulmonary artery smooth muscle cells (PASMCs)
Techniques Used: Knockdown
Figure Legend Snippet: Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) reversed Transforming growth factor-beta1 (TGF-β1)-induced proliferation and migration of pulmonary artery smooth muscle cells (PASMCs)
Techniques Used: Migration
Figure Legend Snippet: Peroxisome proliferatoractivated receptor gamma (PPARγ) cooperates with Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (Cited2) to inhibit the proliferation and migration of pulmonary artery smooth muscle cells (PASMCs)
Techniques Used: Migration